Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Plos One
|
January 9, 2015
KRAS mutation analysis by PCR: a comparison of two methods
Louise Bolton, Anne Reiman, Katie Lucas, et al.
Human Mutation
|
May 12, 2009
Modeling ATM mutant proteins from missense changes confirms retained kinase activity
Giancarlo Barone, Alix Groom, Anne Reiman, et al.
Anticancer Research
|
November 17, 2012
Gene expression and protein array studies of folliculin-regulated pathways
Anne Reiman, Xiaohong Lu, Laurence Seabra, et al.
BMC Cancer
|
February 24, 2017
Validation of an NGS mutation detection panel for melanoma
Anne Reiman, Hugh Kikuchi, Daniela Scocchia, et al.
Journal of the National Cancer Institute
|
June 2, 2005
Cancer risks and mortality in heterozygous ATM mutation carriers
Deborah Thompson, Silvia Duedal, Jennifer Kirner, et al.
Molecular Cancer Therapeutics
|
January 12, 2011
Therapeutic targeting the loss of the birt-hogg-dube suppressor gene
Xiaohong Lu, Wenbin Wei, Janine Fenton, et al.
Annals of Clinical Biochemistry
|
January 10, 2016
Molecular testing for familial hypercholesterolaemia-associated mutations in a UK-based cohort: development of an NGS-based method and comparison with multiplex polymerase chain reaction and oligonucleotide arrays
Anne Reiman, Sarojini Pandey, Kate L Lloyd, et al.
Human Molecular Genetics
|
September 12, 2012
Folliculin interacts with p0071 (plakophilin-4) and deficiency is associated with disordered RhoA signalling, epithelial polarization and cytokinesis
Michael S Nahorski, Laurence Seabra, Ania Straatman-Iwanowska, et al.
BMC Cancer
|
October 25, 2017
The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review
Ian A Cree, Lesley Uttley, Helen Buckley Woods, et al.
Human Mutation
|
May 4, 2011
Birt Hogg-Dubé syndrome-associated FLCN mutations disrupt protein stability
Michael S Nahorski, Anne Reiman, Derek H K Lim, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Plos One
|
January 9, 2015
KRAS mutation analysis by PCR: a comparison of two methods
Louise Bolton, Anne Reiman, Katie Lucas, et al.
Human Mutation
|
May 12, 2009
Modeling ATM mutant proteins from missense changes confirms retained kinase activity
Giancarlo Barone, Alix Groom, Anne Reiman, et al.
Anticancer Research
|
November 17, 2012
Gene expression and protein array studies of folliculin-regulated pathways
Anne Reiman, Xiaohong Lu, Laurence Seabra, et al.
BMC Cancer
|
February 24, 2017
Validation of an NGS mutation detection panel for melanoma
Anne Reiman, Hugh Kikuchi, Daniela Scocchia, et al.
Journal of the National Cancer Institute
|
June 2, 2005
Cancer risks and mortality in heterozygous ATM mutation carriers
Deborah Thompson, Silvia Duedal, Jennifer Kirner, et al.
Molecular Cancer Therapeutics
|
January 12, 2011
Therapeutic targeting the loss of the birt-hogg-dube suppressor gene
Xiaohong Lu, Wenbin Wei, Janine Fenton, et al.
Annals of Clinical Biochemistry
|
January 10, 2016
Molecular testing for familial hypercholesterolaemia-associated mutations in a UK-based cohort: development of an NGS-based method and comparison with multiplex polymerase chain reaction and oligonucleotide arrays
Anne Reiman, Sarojini Pandey, Kate L Lloyd, et al.
Human Molecular Genetics
|
September 12, 2012
Folliculin interacts with p0071 (plakophilin-4) and deficiency is associated with disordered RhoA signalling, epithelial polarization and cytokinesis
Michael S Nahorski, Laurence Seabra, Ania Straatman-Iwanowska, et al.
BMC Cancer
|
October 25, 2017
The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review
Ian A Cree, Lesley Uttley, Helen Buckley Woods, et al.
Human Mutation
|
May 4, 2011
Birt Hogg-Dubé syndrome-associated FLCN mutations disrupt protein stability
Michael S Nahorski, Anne Reiman, Derek H K Lim, et al.
Page
of 2